Evidence demonstrates that just providing prices to employees via an online tool is frequently not helpful. A study of two large employers providing a price transparency tool found no change in healthcare spending and employee uptake…
Fitting with the Trump Administration’s initiation of and Biden Administration’s continued support of price transparency for shoppable outpatient services, research suggests that price transparency is also less impactful in the inpatient setting. Work has demonstrated minimal to no impact of price transparency on ordering labs with display of Medicare prices in the inpatient setting, commonly used imaging studies and inpatient pharmaceuticals, with one study showing a modest impact (~8% decrease) on inpatient lab utilization.
